Skip to content
Join Us
Menu
Home
About
Policy
Science & Innovation
Data
Media
Exothera
Patrick Thiaville, Ph.D
Chief Technology Officer – Nucleic Acids
Exothera
Breaking paradigms with continuous RNA manufacturing.
Enabling therapeutics and vaccines for all.
No scale up from pre-clinical to commercial.
>2x faster and > 2x lower COGs.
Increased quality and yield vs. industry standards.
